AI drug discovery leaders warn U.S. health funding cuts risk falling behind global rivals
Executives from Lila Sciences and NVIDIA told Fortune that the convergence of AI and biology could redefine global competitiveness for decades.
Original Source
Read the full article at Fortune →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.